v3.25.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
ASSETS    
Cash $ 291,571 $ 3,378,152
Digital assets - current (Note 3) 11,399,701 9,021,927
Finance receivables 28,148 21,051
Marketable securities (Note 6) 23,630 27,050
Receivable from sale of Symbiont assets (Note 6)   200,000
Prepaid expenses and other assets 904,079 827,237
Digital assets - collateral (Note 3) 5,500,000  
Income tax receivable 31,187 31,187
Current assets 18,178,316 13,506,604
Fixed assets, net (Note 4) 15,655,533 18,376,948
Intangible assets, net (Note 4) 6,748,137 5,478,958
Deposits on mining equipment (Note 5) 501,228 467,172
Long-term investments - equity securities (Note 6) 5,598 4,255
Investment in Seastar Medical Holding Corporation (Note 6) $ 58,995 $ 200,790
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 3) $ 16,402,955  
Digital assets - collateral (Note 3) 1,430,000 $ 5,000,000
Right of use assets (Note 8) 785,918 938,641
Other assets 389,119 73,857
Long-term assets 41,977,483 30,540,621
Total assets 60,155,799 44,047,225
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 3,071,168 989,563
Note payable - short-term (Note 7) 6,579,828 386,312
Due to related parties (Note 10) $ 59,337 $ 15,944
Other Liability, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 8) $ 190,821 $ 170,967
Total current liabilities 9,901,154 1,562,786
Note payable - long-term (Note 7) 1,243,397 6,365,345
Lease liability - net of current portion (Note 8) 605,234 776,535
Long-term liabilities 1,848,631 7,141,880
Total liabilities 11,749,785 8,704,666
Stockholders' equity (Note 9)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of September 30, 2025 and December 31, 2024
Common stock, par value $.001; 350,000,000 shares authorized; 15,517,988 and 5,133,412 shares issued and outstanding as of September 30, 2025 and December 31, 2024 14,987 4,602
Additional paid-in capital 124,810,596 102,685,470
Accumulated deficit (74,690,296) (65,662,731)
Total LM Funding America stockholders' equity 50,135,287 37,027,341
Non-controlling interest (1,729,273) (1,684,782)
Total stockholders’ equity 48,406,014 35,342,559
Total liabilities and stockholders’ equity $ 60,155,799 $ 44,047,225

Source

HTML PDF
ZIP